About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Ggta1tm1Jbl
targeted mutation 1, John B Lowe
MGI:1857435
Summary 6 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Ggta1tm1Jbl/Ggta1tm1Jbl involves: 129S2/SvPas MGI:3694706
hm2
Ggta1tm1Jbl/Ggta1tm1Jbl involves: 129S2/SvPas * C57BL/6J * DBA/2J MGI:3640394
cx3
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Ightm1Jiac
Igktm1Jiac/Igk+
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 MGI:3779041
cx4
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Igh+
Igktm1Jiac/Igktm1Jiac
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 MGI:3779042
cx5
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Ightm1Jiac
Igktm1Jiac/Igktm1Jiac
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 MGI:3779044
cx6
Cr2tm1Crr/Cr2tm1Crr
Ggta1tm1Jbl/Ggta1tm1Jbl
involves: 129S2/SvPas * 129S7/SvEvBrd MGI:3694708


Genotype
MGI:3694706
hm1
Allelic
Composition
Ggta1tm1Jbl/Ggta1tm1Jbl
Genetic
Background
involves: 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ggta1tm1Jbl mutation (2 available); any Ggta1 mutation (81 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• mutants with pre-existing anti-alpha-Gal antibodies show a median graft survival time of 14 days when ectopically grafted with C57BL/6 hearts; nae mutants with no alpha-Gal antibodies show a graft survival time of >75 days; no rapid graft rejection resembling hyperacute rejection (HAR) seen in humans is observed even with sizeable anti-alpha-Gal IgM antibody titers (J:90851)
• mice can produce antibodies which bind alpha-Gal without need for immunization (J:113488)
• presence of these antibodies increases B and T cell responses to poorly immunogenic antigens expressing alpha-Gal (J:113488)
• significant alpha-BSA-specific IgG antibody levels are observed after immunization of mutants with BSA conjugated to alpha-Gal; antibody production does not require adjuvant
• anti-alpha-Gal IgG titers are low or not detectable in mutants before or after LLCa challenge; antibodies are found in only 33% of orally-immunized mutants pre-LLCa challenge
• naive mice challenged with Lewis Lung Carcinoma cells (LLCa) show production of LLCa-reactive antibodies
• in orally immunized mutants, post-challenge titers are constant or increased from pre-challenge; higher percentage of immunized mice display higher IgM titers post-challenge than nae mice
• mutants with pre-existing anti-alpha-Gal antibodies show a median graft survival time of 14 days when ectopically grafted with C57BL/6 hearts; naive mutants with no alpha-Gal antibodies show a graft survival time of >75 days; no rapid graft rejection resembling hyperacute rejection (HAR) seen in humans is observed even with sizeable anti-alpha-Gal IgM antibody titers

neoplasm
• mutant mice with higher anti-alpha-Gal IgM antibody titers at time of tumor (LLCa) challenge show delayed tumor onset (~20 days) compared to mice with low or no IgM antibodies at challenge (~12 days) suggesting tumor onset and formation times are IgM Ab-concentration dependent

hematopoietic system
• significant alpha-BSA-specific IgG antibody levels are observed after immunization of mutants with BSA conjugated to alpha-Gal; antibody production does not require adjuvant
• anti-alpha-Gal IgG titers are low or not detectable in mutants before or after LLCa challenge; antibodies are found in only 33% of orally-immunized mutants pre-LLCa challenge
• naive mice challenged with Lewis Lung Carcinoma cells (LLCa) show production of LLCa-reactive antibodies
• in orally immunized mutants, post-challenge titers are constant or increased from pre-challenge; higher percentage of immunized mice display higher IgM titers post-challenge than nae mice

respiratory system
• mutant mice with higher anti-alpha-Gal IgM antibody titers at time of tumor (LLCa) challenge show delayed tumor onset (~20 days) compared to mice with low or no IgM antibodies at challenge (~12 days) suggesting tumor onset and formation times are IgM Ab-concentration dependent




Genotype
MGI:3640394
hm2
Allelic
Composition
Ggta1tm1Jbl/Ggta1tm1Jbl
Genetic
Background
involves: 129S2/SvPas * C57BL/6J * DBA/2J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ggta1tm1Jbl mutation (2 available); any Ggta1 mutation (81 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• mice are viable and fertile
• no differences are observed in fertility or litter size are observed compared to wild-type




Genotype
MGI:3779041
cx3
Allelic
Composition
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Ightm1Jiac
Igktm1Jiac/Igk+
Genetic
Background
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ggta1tm1Jbl mutation (2 available); any Ggta1 mutation (81 available)
Ightm1Jiac mutation (0 available); any Igh mutation (44 available)
Igktm1Jiac mutation (0 available); any Igk mutation (26 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• the frequency of B220+ B cells in the periphery is 18.7% compared to 24.7% in mice with just one Igh knock-in allele

hematopoietic system
• the frequency of B220+ B cells in the periphery is 18.7% compared to 24.7% in mice with just one Igh knock-in allele




Genotype
MGI:3779042
cx4
Allelic
Composition
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Igh+
Igktm1Jiac/Igktm1Jiac
Genetic
Background
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ggta1tm1Jbl mutation (2 available); any Ggta1 mutation (81 available)
Ightm1Jiac mutation (0 available); any Igh mutation (44 available)
Igktm1Jiac mutation (0 available); any Igk mutation (26 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• the frequency of B220+ B cells in the periphery is 10.1% compared to 24.7% in mice with just one Igk knock-in allele

hematopoietic system
• the frequency of B220+ B cells in the periphery is 10.1% compared to 24.7% in mice with just one Igk knock-in allele




Genotype
MGI:3779044
cx5
Allelic
Composition
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Ightm1Jiac
Igktm1Jiac/Igktm1Jiac
Genetic
Background
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ggta1tm1Jbl mutation (2 available); any Ggta1 mutation (81 available)
Ightm1Jiac mutation (0 available); any Igh mutation (44 available)
Igktm1Jiac mutation (0 available); any Igk mutation (26 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• anti-alphaGal IgM is detectable in the sera of mice
• the frequency of B cells expressing anti-alphaGal IgM in the spleen is higher than controls
• the frequency of B220+ B cells in the periphery is 6.6% compared to 24.7% in mice with just one knock-in allele for Igk and Igh
• the anti-alphaGal IgM produced by B cells has a lower affinity for antigen than immunoglobulins produced in mice with with no endogenous expression of alphaGal

immune system
• anti-alphaGal IgM is detectable in the sera of mice
• the frequency of B cells expressing anti-alphaGal IgM in the spleen is higher than controls
• the frequency of B220+ B cells in the periphery is 6.6% compared to 24.7% in mice with just one knock-in allele for Igk and Igh
• the anti-alphaGal IgM produced by B cells has a lower affinity for antigen than immunoglobulins produced in mice with with no endogenous expression of alphaGal




Genotype
MGI:3694708
cx6
Allelic
Composition
Cr2tm1Crr/Cr2tm1Crr
Ggta1tm1Jbl/Ggta1tm1Jbl
Genetic
Background
involves: 129S2/SvPas * 129S7/SvEvBrd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cr2tm1Crr mutation (0 available); any Cr2 mutation (84 available)
Ggta1tm1Jbl mutation (2 available); any Ggta1 mutation (81 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• double mutants do not produce alpha-Gal-reactive natural antibodies; Ggta1-null and double mutants given anti alpha-Gal serumproduce similar levels of BSA-specific IgG antibodies after alpha-Gal immunization, indicating that complement receptors are not required to produce increased carrier immunogenicity
• elevated BSA immunogenicity in mutants is directly related to alpha-Gal specific antibodies





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory